↓ Skip to main content

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort

Overview of attention for article published in HIV Medicine, January 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
82 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort
Published in
HIV Medicine, January 2019
DOI 10.1111/hiv.12710
Pubmed ID
Authors

JM Llibre, A Montoliu, JM Miró, P Domingo, M Riera, J Tiraboschi, A Curran, F Homar, J Ambrosioni, N Abdulghani, L Force, J Peraire, J Casabona, PISCIS Cohort group

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 82 100%

Demographic breakdown

Readers by professional status Count As %
Other 12 15%
Student > Postgraduate 8 10%
Student > Master 6 7%
Researcher 5 6%
Professor > Associate Professor 5 6%
Other 19 23%
Unknown 27 33%
Readers by discipline Count As %
Medicine and Dentistry 34 41%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Immunology and Microbiology 3 4%
Computer Science 2 2%
Neuroscience 2 2%
Other 5 6%
Unknown 30 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2024.
All research outputs
#6,837,088
of 25,372,398 outputs
Outputs from HIV Medicine
#394
of 1,377 outputs
Outputs of similar age
#127,064
of 448,591 outputs
Outputs of similar age from HIV Medicine
#9
of 19 outputs
Altmetric has tracked 25,372,398 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 1,377 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,591 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.